Similar articles

• hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120.

  Safrit JT, Fung MS, Andrews CA, Braun DG, Sun WN, Chang TW, Koup RA. Safrit JT, et al. AIDS. 1993 Jan;7(1):15-21. doi: 10.1097/00002030-199301000-00002. AIDS. 1993. PMID: 7680205
• Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant.

  Andrus L, Prince AM, Bernal I, McCormack P, Lee DH, Gorny MK, Zolla-Pazner S. Andrus L, et al. J Infect Dis. 1998 Apr;177(4):889-97. doi: 10.1086/515251. J Infect Dis. 1998. PMID: 9534960
• Involvement of the complement system in antibody-mediated post-exposure protection against human immunodeficiency virus type 1.

  Gauduin MC, Weir R, Fung MS, Koup RA. Gauduin MC, et al. AIDS Res Hum Retroviruses. 1998 Feb 10;14(3):205-11. doi: 10.1089/aid.1998.14.205. AIDS Res Hum Retroviruses. 1998. PMID: 9491910
• Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID mice.

  Koup RA, Safrit JT, Weir R, Gauduin MC. Koup RA, et al. Semin Immunol. 1996 Aug;8(4):263-8. doi: 10.1006/smim.1996.0033. Semin Immunol. 1996. PMID: 8883150 Review.
• Prospects for passive immunity to prevent HIV infection.

  Morris L, Mkhize NN. Morris L, et al. PLoS Med. 2017 Nov 14;14(11):e1002436. doi: 10.1371/journal.pmed.1002436. eCollection 2017 Nov. PLoS Med. 2017. PMID: 29136030 Free PMC article. Review.